Premas Life Sciences Pvt Ltd. Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Premas Life Sciences Pvt Ltd.'s estimated annual revenue is currently $22.9M per year.(i)
  • Premas Life Sciences Pvt Ltd.'s estimated revenue per employee is $155,000

Employee Data

  • Premas Life Sciences Pvt Ltd. has 148 Employees.(i)
  • Premas Life Sciences Pvt Ltd. grew their employee count by -1% last year.

Premas Life Sciences Pvt Ltd.'s People

NameTitleEmail/Phone
1
Brand ManagerReveal Email/Phone
2
Clinical Genomics - Product ManagerReveal Email/Phone
3
Area ManagerReveal Email/Phone
4
Dedicated Field Application Scientist for NCAAH,Cusat-KochiReveal Email/Phone
5
Lead ScientistReveal Email/Phone
6
Customer Support ExecutiveReveal Email/Phone
7
Field Services EngineerReveal Email/Phone
8
Sr. Field Service EngineerReveal Email/Phone
9
Regional Sales Manager - WestReveal Email/Phone
10
Field Services EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23.1M149-4%N/AN/A
#2
$42.2M27218%N/AN/A
#3
$27M17433%N/AN/A
#4
$27M17464%N/AN/A
#5
$22.9M14820%N/AN/A
#6
$46.5M30010%N/AN/A
#7
$29.3M1899%N/AN/A
#8
$47M30324%N/AN/A
#9
$30.8M19924%N/AN/A
#10
$33.8M218-17%N/AN/A
Add Company

What Is Premas Life Sciences Pvt Ltd.?

WE are a young, ambitious and focussed company based bringing cutting edge solutions to the Indian Research and Applied Markets. For more check out: https://goo.gl/BBKkhk

keywords:N/A

N/A

Total Funding

148

Number of Employees

$22.9M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Premas Life Sciences Pvt Ltd. News

2022-04-06 - DNA Script Partners with Asia-Pacific Distributors as Part of ...

(Singapore), Premas Life Sciences Pvt. Ltd. (India) and Bio-Medical Science Co. Ltd. (South Korea). These partnerships expand DNA Script's...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A149-38%N/A
#2
$23.1M149-4%N/A
#3
$33.2M15032%N/A
#4
$27.4M151-3%N/A
#5
$16.9M15132%N/A